hepatoma Clinical Research Trials

Please select a valid location from the dropdown

Found 837 clinical trials

featured

Early-stage Hepatocellular Carcinoma

People with liver cirrhosis and recently diagnosed (not yet treated) early-stage hepatocellular carcinoma are asked to participate in a research study being conducted by Montefiore Medical Center

54 views
23 Nov, 2020
1 location

featured

AHEP0731: Combination Chemotherapy in Treating Young Patients with Newly Diagnosed Liver Cancer

400 views
07 Nov, 2020
1 location

featured

CALGB 80802: A Phase III Randomized Study of Sorafenib plus Doxorubicin Versus Sorafenib in Patients with Advanced Hepatocellular Carcinoma (HCC).

84 views
08 Nov, 2020
1 location

YIV-906 (Formerly PHY906/KD018) With Sorafenib in HBV(+) Hepatocellular Carcinoma (HCC)

Hepatitis B (+) associated advanced hepatocellular carcinoma. YIV-906 (PHY906, KD018) is an immune system modulator. Clinical and preclinical research suggests that YIV-906 could act to enhance the

2 views
27 Jan, 2021
32 locations

Safety and Efficacy of Coformulated Pembrolizumab/Quavonlimab (MK-1308A) in Combination With Lenvatinib (E7080/MK-7902) in Advanced Hepatocellular Carcinoma (MK-1308A-004)

The purpose of this study is to evaluate the safety and efficacy of fixed dose coformulated pembrolizumab/quavonlimab (MK-1308A) plus lenvatinib in a first line (1L) hepatocellular carcinoma

0 views
11 Apr, 2021
7 locations

DRAGON 1- Training Accreditation Implementation and Safety Evaluation of Combined PVE/HVE

Brief Summary: Some colorectal liver metastases can only be resected after inducing liver regeneration by portal vein embolization (PVE) to increase size function of the future liver remnant (FLR). While PVE is standard, embolization of portal vein and hepatic veins (PVE/HVE) on one side of the liver may faster and …

0 views
05 Mar, 2021
28 locations

A Study to Evaluate SHR-1210 in Combination With Apatinib as First-Line Therapy in Patients With Advanced HCC

patients with advanced HCC.

9 views
23 Jan, 2021
35 locations

A Study of JNJ 73763989+JNJ 56136379+Nucleos(t)Ide Analog (NA) Regimen Compared to NA Alone in e Antigen Negative Virologically Suppressed Participants With Chronic Hepatitis B Virus Infection

The purpose of this study is to evaluate the efficacy of 48-week study intervention with JNJ-73763989+JNJ-56136379+nucleos(t)ide analog (NA) regimen compared to NA alone assessed by HBsAg levels. This study is part of HepB Wings Platform Trial (PLATFORMPAHPB2001).

6 views
01 Mar, 2020
32 locations

MPA Versus Dydrogesterone for Management of Endometrial Hyperplasia Without Atypia

To compare the efficacy of Medroxyprogesterone Acetate with dydrogesterone in patients having endometrial hyperplasia (EH) without atypia.

0 views
25 Jan, 2021
1 location

Establishment of a Personalized Pharmaceutical Plan in Renal or Hepatic Transplant Patients

The main objective of the study is to evaluate the impact of the Personalized Pharmaceutical Plan on the therapeutic adherence to immunosuppressive treatments one year after liver or kidney transplantation.

0 views
26 Feb, 2021
12 locations

Filter By

Found 837 clinical trials